This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Andrew J Neel: Innovator in Nucleotide Synthesis
Introduction
Andrew J Neel is a prominent inventor based in Jersey City, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of fluorinated nucleotides. His work has implications for various applications in pharmaceuticals and biotechnology.
Latest Patents
Andrew J Neel holds a patent for the "Synthesis of Fluorinated Nucleotides." This innovation showcases his expertise in developing advanced chemical processes that can enhance the efficacy of nucleotides used in various applications.
Career Highlights
Neel is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role at Merck allows him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative solutions.
Collaborations
Throughout his career, Andrew has collaborated with notable colleagues, including Jeffrey C Moore and Heather Claire Johnson. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Andrew J Neel is a dedicated inventor whose work in the synthesis of fluorinated nucleotides exemplifies innovation in the field of biochemistry. His contributions continue to influence advancements in healthcare and biotechnology.